Cormorant Asset Management’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-625
| Closed | -$5.58M | – | 55 |
|
|
2017
Q3 | $5.58M | Hold |
625
| – | – | 0.98% | 30 |
|
|
2017
Q2 | $4.69M | Hold |
625
| – | – | 0.78% | 38 |
|
|
2017
Q1 | $4.01M | Buy |
625
+343
| +122% | +$2.2M | 0.58% | 45 |
|
|
2016
Q4 | $3.21M | Hold |
282
| – | – | 0.43% | 50 |
|
|
2016
Q3 | $3.94M | Hold |
282
| – | – | 0.43% | 58 |
|
|
2016
Q2 | $4.29M | Buy |
282
+3
| +1% | +$45.6K | 0.61% | 46 |
|
|
2016
Q1 | $3.46M | Buy |
279
+188
| +207% | +$2.33M | 0.52% | 47 |
|
|
2015
Q4 | $1.78M | Hold |
91
| – | – | 0.21% | 63 |
|
|
2015
Q3 | $1.23M | Hold |
91
| – | – | 0.2% | 69 |
|
|
2015
Q2 | $1.56M | Hold |
91
| – | – | 0.21% | 64 |
|
|
2015
Q1 | $1.69M | Buy |
91
+16
| +21% | +$297K | 0.26% | 57 |
|
|
2014
Q4 | $921K | Hold |
75
| – | – | 0.14% | 63 |
|
|
2014
Q3 | $1.1M | Hold |
75
| – | – | 0.23% | 59 |
|
|
2014
Q2 | $1.31M | Buy |
+75
| New | +$1.31M | 0.35% | 49 |
|